Document Detail


Separation of the tumor rejection antigen of Rous sarcoma virus-induced murine fibrosarcoma.
MedLine Citation:
PMID:  2453498     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The tumor antigen capable of inducing tumor resistance (tumor rejection antigen; TRA) was separated and some of its physicochemical properties were characterized. Cytosol and plasma membrane fractions were separated from Rous sarcoma virus (RSV)-induced CSA1M tumor cells. Immunization with membrane but not cytosol fraction of these tumor cells together with complete Freund's adjuvant resulted in complete protection against subsequent challenge with viable CSA1M cells. The TRA activity contained in the membrane fraction was recovered in the sodium dodecyl sulfate (SDS)-solubilized fraction after the SDS-extraction of CSA1M membranes. This CSA1M SDS-solubilized preparation gave protection against syngeneic RSV-induced CSA9F tumor cells as well as the homologous tumor cell type, but failed to induce resistance to RSV-unrelated tumor cells. The membrane or SDS-solubilized fraction from RSV-unrelated tumor cells was unable to generate anti-CSA1M protective immunity. Physicochemical analyses have demonstrated that TRA activity in the SDS-solubilized fraction was completely abolished by treatment with proteinase K but was only marginally affected after treatment with glycosidase mixture. When the SDS-solubilized preparation was applied to a Sephacryl S-300 superfine column, TRA activity was recovered in the range of molecular weight of 50-90 kD. Further fractionation of this TRA-positive fraction by SDS-polyacrylamide gel electrophoresis revealed that the molecular size of TRA is 56-68 kD. These results indicate that membrane proteins which were isolated from CSA1M tumor cells and have a molecular size of about 60 kD are capable of inducing RSV-induced tumor-specific in vivo protective immunity.
Authors:
T Suda; J Shimizu; Y Mizushima; H Fujiwara; T Hamaoka
Related Documents :
20403708 - Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation.
20661468 - Tumor-derived microvesicles induce, expand and up-regulate biological activities of hum...
11924908 - Antitumor effects of flt3 ligand in transplanted murine tumor models.
10505988 - Current perspectives in immunotherapy.
21521438 - Canine conjunctival mast cell tumors: a retrospective study.
19846868 - Activated cd4+ t cells dramatically enhance chemotherapeutic tumor responses in vitro a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Japanese journal of cancer research : Gann     Volume:  79     ISSN:  0910-5050     ISO Abbreviation:  Jpn. J. Cancer Res.     Publication Date:  1988 Mar 
Date Detail:
Created Date:  1988-06-24     Completed Date:  1988-06-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8509412     Medline TA:  Jpn J Cancer Res     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  365-74     Citation Subset:  IM    
Affiliation:
Department of Oncogenesis, Institute for Cancer Research, Osaka.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, Neoplasm / immunology,  isolation & purification*,  physiology
Antigens, Surface / immunology,  isolation & purification*
Avian Sarcoma Viruses*
Cell Fractionation
Cell Line
Cell Transformation, Viral
Endopeptidase K
Epitopes / immunology
Fibrosarcoma / etiology,  immunology*,  therapy
Graft Rejection*
Growth Inhibitors / isolation & purification,  physiology
Male
Membrane Glycoproteins / immunology,  isolation & purification,  physiology
Mice
Mice, Inbred BALB C
Sarcoma, Experimental / etiology,  immunology*,  therapy
Serine Endopeptidases / pharmacology
Sodium Dodecyl Sulfate
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm; 0/Antigens, Surface; 0/Epitopes; 0/Growth Inhibitors; 0/Membrane Glycoproteins; 0/sarcoma glycoprotein gp96 rejection antigens; 151-21-3/Sodium Dodecyl Sulfate; EC 3.4.21.-/Serine Endopeptidases; EC 3.4.21.64/Endopeptidase K

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Establishment and characterization of a woodchuck hepatocellular carcinoma cell line (WH44KA).
Next Document:  Effect of increased surface tension and assisted ventilation on 99mTc-DTPA clearance.